|
|
name  click to compare prices |
| Actara, Aviva | | Calcium Sandoz, Capstar, Céréal, Ciba-Geigy, CibaVision, Cloomicalm, Clordane, Clozaril, Cruiser | | Desenex, Dulcolax | | Econor, Eden, Endosulfan, Eon Labs (67,4%), Exlax | | Fenistil, Frutiva | | Gas-X, Geneva Pharmaceuticals, GNR Pharma, Grandis Biotech GmbH | | Habitrol, Hepthaclor | Immerge BioTherapeutics (50%), Importal, Imutran, Isosource, Isostar  | | Lamisil, Lek, Lemocin, Lindane | | Maalox, Maïs Bt, Mebucasol, Meriten, Milical, Modar | Neda, Neocitran, NeuTec, Nicotinell, Novartis  , Nutrodip | | Oclea, Optalidon, Otrivin | | Perdiem, Piz Buin, Protez | | Resource, Rhinomer | | Sabex, Sandoz, Sangerol, Speedel | | Tavist, Theraflu, Triaminic, Trileptal | | Vegumine, Venoruton, Vivonex | | Zymafluor |
» Shop local, ethical and at the best price on Ethishop  |
|
| |
|
| shareholder | country | % | source |
|
year | business source |
| 2007 | Novartis sells 13,2% of the generic drugs bought in France. | Les Echos |
| 2006 | Europe's third-largest drugmaker | Bloomberg |
| 2006 | Novartis sells 5% of the vaccines bought in the world. | Les Echos |
| 2006 | Novartis is the world's third-largest pharmaceutical group. | Les Echos |
| 2004 | Novartis is the largest generic drug maker in the world. | Company |
| 2004 | Novartis sells 11% of the tobacco substitutes bought in France | Les Echos |
|
| country | address & contact : production type incentive source |
 Bermuda | Triangle International Reinsurance Ltd., Hamilton :  Company |
| Bermuda | Novartis International Pharmaceutical Ltd., Hamilton : Company |
 Brazil | Novartis Seeds Limitada, Sao Paulo : Company |
 Chile | Novartis Chile SA, Santiago : Company |
 China | Novartis' 8th global research center : Company |
| China | Beijing Novartis Pharma Ltd. Beijing : Company |
| China | Shangai Novartis Nutricion Ltd. : Company |
 Colombia | Novartis de Colombia, Santafé : Company |
 Costa Rica | Productos Gerber de Centroamerica SA, San José : Company |
 Egypt | Novartis Pharma SAE, Cairo : Company |
 Hungary | Novartis Seeds Kft. Budapest : Company |
 India | Novartis Entreprises, Mumbai : Company |
| India | Novartis India Ltd., Mumbai : Company |
 Indonesia | PT Novartis Biochemie, Jakarta : Company |
 Mexico | Ciba, JALISCO CHAPALA GUADALAJARA - OCOTLAN KM 4.5 & 373 70650 : Sistema de Informacion de la Industria Maquiladora |
| Mexico | CARR. MEX-TLAX. 5000 LAS FABRICAS N/D PUEBLA PUEBLA & 481199 : Sistema de Informacion de la Industria Maquiladora |
| Mexico | DISTRITO FEDERAL COYOACAN TLALPAN 3058 STA. URSULA COAPA & 4226340 : Sistema de Informacion de la Industria Maquiladora |
 Pakistan | Novartis Pharma Ltd. Karachi : Company |
 Philippines | Novartis Agro Philippines Inc., Makati/Manila : Company |
| Philippines | Novartis Healthcare Philippines Inc., Makati/Manila : Company |
| Philippines | Novartis Nutricion Philippines Inc. Pasig/Manila : Company |
 Poland | Alima/Gerber SA Warsaw : Company |
 Singapore | Novartis Crop Protection Pte Ltd. : Company |
 Thailand | Novartis Nutricion Ltd. : Company |
 Turkey | Novartis Saglik, Istanbul : Company |
| Turkey | Ciba-Geigy : US Government Country Business Profile |
 Uruguay | Novartis Uruguay SA, Montevideo : Company |
 Venezuela | Novartis Nutricion de Venezuela SA, Caracas : Company |
 Vietnam | Novartis Ltd. Bien Hoa City : Company |
|
| year name | photo position; compensation source |
| 2006Vasella, Daniel |  Chief Executive Officer; salary: 2.72 million US$; Company |
| 2004Vasella, Daniel | Chief Executive Officer; salary: 13.59 million Eu€; AGEFI |
| 2000Kindler, Hans | Executive committee; Corporate Europe Observatory |
|
| year | employees <> | social impact : country source |
| 2008 | -550 | Internal restructuring: Novartis changes the management of three of four business units and is cutting 550 jobs in U.S. marketing.: United States of America | Bloomberg |
| 2008 | -2500 | Internal restructuring: Novartis cuts 2500 jobs to save 1,6 billion dollars per year after 2008. Four drugs are competed by generic drugs and a fifth one was withdrawn because of dangerous side effects.: | Les Echos |
| 2005 | | Douze employées ou ex-employées de Novartis ont porté plainte à New York contre le groupe suisse. Elles l'accusent de discriminer sexiste, en matière de salaires, de qualifications, de promotions, de formation continue et de pratiques disciplinaires. Elles réclament 100 millions de dollars de dédommagement. Novartis a réfuté les accusations portées à son encontre.: United States of America | Tsr.ch |
| 2004 | | Le tribunal de grande instance condamne Novartis à retirer certaines dispositions de son code de conduite à l'usage de ses employés: France | Les Barons Marqués |
| 1989 | -150 | | Canadian Labour Congress |
|
| year | employees <> | social impact : country source |
|
| year | country : consequences source |
| 2007 | France : Between 1950 and 1960, Novartis and other chemical industries of Basle illegally discarded 600 tons of nitrobenzine and other dyes synthesis products. The site was discovered by chance by a farmer of Hagenthal-le-bas. | Les Echos |
| 2005 | United States of America brand: Trileptal : Serious skin reactions including skin disorders called toxic epidermal necrolysis and Stevens-Johnson syndrome. | Reuters |
| 2005 | brand: Clozaril : Older patients with dementia who are given antipsychotic medicines are far more likely to die prematurely than those given placebos. Most died of heart-related problems like heart failure or infections like pneumonia (FDA). | New York Times |
| 2004 | : Stockage de 150 000 tonnes de déchets chimiques à Bonfol entre 1961 et 1976 à dix mètres de profondeur, sur une superficie de 20.000 m2. | AFP |
| 2002 | France : Production, purchase or sale of genetically modified organisms which may cause an irreversible genetic pollution, a destruction of the biodiversity and health risks for the consumers. | UFC Que Choisir |
| 2000 | : Explosion | Swissinfos |
| 1999 | brand: Céréal : Risque alimentaire (OGM) | UFC Que Choisir |
| 1986 | France : Sandoz, pollution du Rhin | Company |
| | : Production, purchase or sale of genetically modified organisms which may cause an irreversible genetic pollution, a destruction of the biodiversity and health risks for the consumers. | The Guardian |
|
| year | country : consequences source |
|
| year | country : description |
| 2004 | South Korea : Le glivec permet de maintenir en vie les patients atteints par la leucemie myeloïde. Prix du traitement: 55000 euros/an. Le glivec a été développé largement grâce à des financements publics | Arte |
|
| year | country : description source |
|
| year | financial misdemeanor | sales | income | | buyback | source |
| 2006 |
| 36.75 | 5.26 | | | billion US$ | Company |
| 2005 |
| 32.53 | 5.19 | | | billion US$ | Company |
| 2005 |
Sued by the State of California for defrauding the state's $34 billion Medi-Cal program by inflating prices. "We're going to drag these drug companies into courts of law because they've been gouging the public," California Attorney General Bill Lockyer said at a news conference. For example, Medi-Cal paid $804.70 US for a bottle of the hypertension drug Atenolol. Providers such as doctors, clinics and pharmacists paid $33.85 US. As a result, providers reimbursed by Medi-Cal for Atenolol pocketed $770.85 US. The windfalls gave doctors, pharmacies and other providers an incentive to prescribe such drugs, which resulted in even more sales by drug makers, Lockyer said. |
| | | | | | Canadian Press |
| 2005 |
| | | | 2.567 | billion Eu€ | Le Point |
| 2004 |
| 28.25 | 5.77 | | 0.675 | billion Eu€ | La Tribune |
| 2003 |
| 24.86 | 5.02 | | | billion Eu€ | Company |
| 2002 |
| 23.15 | 5.22 | | | billion US$ | Company |
| 2001 |
| 19.34 | 4.24 | | | billion US$ | Company |
| 2000 |
| 17.47 | 3.91 | | | billion US$ | Company |
| 1999 |
| 18.71 | 4.94 | | | billion US$ | Company |
| 1998 |
| 17.2 | 4.46 | | | billion US$ | Company |
|
| year | financial misdemeanor | sales | income | assets | buyback | source |
|
| year | purpose : intermediary/lobby : institution source |
| 2004 | Avoid compulsory licensing of the glivec : : Secretary of State  translate | Arte |
| 2001 | Access to foreign market (through MAI, WTO, GATS), prevent binding environmental regulations : USCIB (US Council For International Business) : : US Government translate | USCIB |
| 2000 | Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translate | Washington Post |
| 2000 | Prevent binding environmental regulations (environmental protection through economic growth, self-regulation and free trade) : WBCSD (World Business Council for Sustainable Development) : : United Nations translate | Corporate Europe Observatory |
| 2000 | Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translate | EFPIA |
| 2000 | Market access (through WTO), cheaper energy (through energy liberalization in Europe); uniform rules to enable the patenting of plants and animals (through TRIPS); prevent advert legislation on chemicals, self-regulation instead; : CEFIC (European Chemical Industry Council) : : European Commission translate | Corporate Europe Observatory |
| 2000 | lift the ban on bovine growth hormon : FEDESA : : European Commission translate | Fedesa |
| 1999 | Market access and investment protection (through WTO, GATS), avoid social and environmental rules : ICC (International Chamber of Commerce) : : WTO, GATS translate | Corporate Europe Observatory |
| 1999 | Market admission for genetically modified organisms : EuropaBio : : European Commission translate | Corporate Europe Observatory |
| 1998 | Regulation favorable to company's interests : Contribution to Candidate's Political Action Committee : amount: 156 thousand US$ : US President, Congress, Senate translate | Center for Responsive Politics |
| 1998 | Regulation favorable to company's interests : Contribution to Candidate's Political Action Committee : amount: 15 thousand US$ : US President, Congress, Senate translate | Center for Responsive Politics |
|
| year | purpose : intermediary/lobby : institution source |
|
| year | dubious practice : image source |
| 2006 | Biopiracy - Appropriation of public knowledge: Novartis sues India to prevent it from producing a generic version of its drug, in spite of the international authorization of the agreements on the intellectual property (TRIPS).: | AFP |
| 2005 | Disinformation: Estradot, an estrogen patch for women made by drug industry giant Novartis, has been promoted in Australia by a fake news package including a press release, a video news release (VNR) and an audio news release (ANR). The VNR was used without attribution by Channel 7 News. MediaWatch presenter, Liz Jackson, reported that "on radio it was everywhere, over and over again, using only the medical experts the PR company provided." Potential side effects, Jackson reported, were "almost completely ignored by the media, except when one of the company's experts raised it herself to dismiss lingering concerns.: | ABC |
| 2004 | Arguable partnership: Alliance globale pour le développement de médicament contre la tuberculose (TB Alliance), Singapoure: value: humanitaire; | Les Barons Marqués |
| 2001 | ad budget: 306 million US$; | Advertising Age |
| 2000 | ad budget: 324 million US$; | Advertising Age |
| 2000 | Arguable partnership: Global Compact with the United Nations: value: Respects human, social and environmental laws; | ONU |
| 1999 | slogan: Maalox, on vit vraiment mieux sans brulures d'estomac.; | Company |
| 1998 | ad budget: 335 million US$; | Advertising Age |
| 1997 | ad budget: 350 million US$; | Advertising Age |
| 1990 | slogan: Win the instar wars. Javelin by Sandozcrop protection.; | Company |
|
|
|
Contribute
&sa=OK&client=pub-2642534665785160&forid=1&channel=6290198667&ie=ISO-8859-1&oe=ISO-8859-1&flav=0002&sig=NuXwWEvBGZspbgPc&cof=GALT%3A%23CEA7FF%3BGL%3A1%3BDIV%3A%234A4A4A%3BVLC%3AFF6600%3BAH%3Acenter%3BBGC%3A4A4A4A%3BLBGC%3A4A4A4A%3BALC%3AFFB42D%3BLC%3AFFB42D%3BT%3AFFFFFF%3BGFNT%3AE8DBEF%3BGIMP%3ACEA7FF%3BLH%3A26%3BLW%3A304%3BL%3Ahttp%3A%2F%2Fwww.transnationale.org%2Fimages%2Ftrans2.gif%3BS%3Ahttp%3A%2F%2Fwww.transnationale.org%3BFORID%3A11&hl=en){kind=link}
&sa=OK&client=pub-2642534665785160&forid=1&channel=6290198667&ie=ISO-8859-1&oe=ISO-8859-1&flav=0002&sig=NuXwWEvBGZspbgPc&cof=GALT%3A%23CEA7FF%3BGL%3A1%3BDIV%3A%234A4A4A%3BVLC%3AFF6600%3BAH%3Acenter%3BBGC%3A4A4A4A%3BLBGC%3A4A4A4A%3BALC%3AFFB42D%3BLC%3AFFB42D%3BT%3AFFFFFF%3BGFNT%3AE8DBEF%3BGIMP%3ACEA7FF%3BLH%3A26%3BLW%3A304%3BL%3Ahttp%3A%2F%2Fwww.transnationale.org%2Fimages%2Ftrans2.gif%3BS%3Ahttp%3A%2F%2Fwww.transnationale.org%3BFORID%3A11&hl=en){kind=link}
